Canadians: 2 Revolutionary Growth Stocks to Buy on Sale!

Docebo (TSX:DCBO)(NASDAQ:DCBO) and Dye & Durham (TSX:DND) are Canadian revolutionary growth stocks that are cheaper than they look.

| More on:

Canadians don’t need to venture south of the border for their high-tech growth exposure any longer, not with the growing number of revolutionary growth stocks on the TSX Index. In this piece, we’ll have a closer look at three Canadian stocks that may soon attract the attention of our growth-savvy friends to the south, as Shopify stock has over the past few years.

Without further ado, consider Docebo (TSX:DCBO)(NASDAQ:DCBO) and Dye & Durham (TSX:DND). Two early-stage growth stories that young Canadian investors should subscribe to today.

A great play on the future of work

Docebo is becoming more of a household name after a pandemic-plagued year that forced many workforces to embrace work from home. Working from home can be tough. Productivity can be lost, and that calls for infrastructure like Docebo’s AI-leveraging offering that can minimize or even enhance the productivity of remote workforces.

Things are bound to return to normal with vaccines rolling out, and many remote workers will be heading back to the office. Some firms may be more inclined to stick with the work-from-home model, either due to productivity enhancements, cost savings, or both. Many pundits argue that work-from-anywhere is the future and that we’ll witness a blend of remote and office work once the pandemic is over.

If this is, indeed, what will happen, office real estate will take a permanent blow. And WFH plays like Docebo will be taking budget that would have otherwise been spent on leasing pricy office space.

Docebo is one of many revolutionary growth stocks to play the future of work. And right now, I think the stock seems too cheap for its own good. The name is off 30% from its high but could be in a position to bounce once the sellers exhaust themselves. Yes, Docebo still looks expensive at 24 times sales. But is it really that expensive given the massive total addressable market that the firm can carve out for itself over the coming years? I’d argue it’s not.

Worth paying up for!

Dye & Durham is another productivity-enhancing software company that’s harnessed the power of the cloud. The firm has narrowed its sights on its niche (legal and business), and it’s going after it in a big way. As most other software companies spread themselves too thin, Dye & Durham is perfectly fine with building upon its moat.

The stock recently surged 10% on Thursday, an explosive move that could be the start of a sustained rally to even greater heights. The company posted some impressive (nearly triple-digit) growth numbers in its last quarterly report. Even after the recent pop in the revolutionary growth stock, I don’t think the valuation fully reflects Dye’s longer-term potential.

Like Docebo, DND stock trades at a ridiculously high price-to-sales (P/S) multiple. After the latest pop, DND boasts a P/S north of 33.

While that seems expensive, is it really given the growth you’re getting? Analysts certainly don’t seem to think so. Robert Young of Canaccord Genuity has a $60 price target on shares, implying another 34% worth of upside could be in the cards.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Shopify.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »